Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.
about
Genetics and age-related macular degeneration: a practical review for the clinicianThe Application of Genetic Risk Scores in Age-Related Macular Degeneration: A ReviewAdvances in the genomics of common eye diseasesGenetic and environmental underpinnings to age-related ocular diseasesPrivacy in the Genomic EraHeritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypesSeven new loci associated with age-related macular degeneration.Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.A risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts.Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration.Modelling the genetic risk in age-related macular degeneration.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Comparative analysis of circulating endothelial progenitor cells in age-related macular degeneration patients using automated rare cell analysis (ARCA) and fluorescence activated cell sorting (FACS).Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study.Phototoxic action spectrum on a retinal pigment epithelium model of age-related macular degeneration exposed to sunlight normalized conditionsCommon variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levelsDifferences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical SubtypesProspective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov modelsA Validated Phenotyping Algorithm for Genetic Association Studies in Age-related Macular Degeneration.A local complement response by RPE causes early-stage macular degeneration.Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.The association between statin use and risk of age-related macular degeneration.Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study.Adaptive optics technology for high-resolution retinal imagingComplement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis.Genetic Association Analysis of Drusen Progression.Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophyDietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophyClinical neurogenetics: stroke.Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: a preliminary reportThe Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration.The Association between LIPC rs493258 Polymorphism and the Susceptibility to Age-Related Macular Degeneration.Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration.Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus.Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration.
P2860
Q26738526-DE16DC0E-564F-46C0-B1D2-7663CD307020Q26766721-D163EF08-8004-4121-ADF9-CCBEA1B5637EQ27008236-09DCEBA5-436B-4820-9B9F-38A4E3FDEB17Q27013719-10182633-FA4D-4E5D-98D1-33F1D92AEAA0Q27316478-BC30495A-165F-44C6-B68D-0237184710BFQ28943546-6F7E95A7-9DFE-4802-961B-C85ECEBA9836Q29416998-11D23F5F-09FC-41DA-BB3B-94D85682AD82Q29417048-CCB1F53F-8CCE-4935-ABE1-44103FB89890Q30683824-E61FAAF6-02B2-44E7-BE90-A639D2227DB4Q33849399-2A1A4E57-7ADE-4341-A5DA-F878718FC739Q34155381-8387826C-E23C-40E0-9662-68A1EC467E21Q34292742-14FCD708-2A94-4AFA-B8D5-6154AB5372B6Q34518507-F01FA216-748E-4491-95D0-1F68A737A235Q34566273-FE9D573A-C0B9-412C-B42E-70D67CB7E9DDQ34806228-8BF7AE0D-D35A-4931-97A4-E66167D1AC10Q34994172-0CE6F03B-CBDE-441A-A668-10B9BC424B04Q35175046-0280C206-705D-4BF4-8AE3-2A6EA1A2FA17Q35509582-2CED9B40-5D55-4B9C-9BF3-FAB7B1BF98C1Q35693886-42E52DB2-4050-4BCF-B8A7-6572ED4FFF08Q35870337-8EE6B2EE-2905-4A94-A770-DA7AD9D7C602Q35921473-9B61D2D6-DEAF-4252-A00B-B3A0E2CF2C5AQ35932943-C85D882D-76ED-47B0-9033-E8CED0C9E400Q36065466-6B72F986-2C6A-44D5-A49A-9F7EBC3F775EQ36084168-2245B4F1-DBCF-4ACA-B379-6C6DE077EE17Q36194390-44A97AD9-7D6B-461D-A80B-097FCBB3E719Q36367171-6A020B48-A7D2-4B52-A4B5-C92417897A53Q36391339-B8CB43F1-BCD4-4BA1-A549-789413B804DFQ36616252-B21C645A-EDD5-441F-841E-01A5ACDE1EC7Q36634694-A6857AC8-35F2-4532-80F3-AE1187D4BCFEQ36849277-87718DF7-3D81-4A30-B36A-5DA7FF43E6BBQ36933119-8E3938DA-E2C1-41C8-ACEC-81C7FB979561Q36961648-DC6E6123-157B-4C3E-A7E2-D2BE0A59EEB8Q37134473-7A824DA9-58FF-4EBC-977F-7A2506890E7EQ37274532-CFEB6F88-28DD-4EE1-B49B-0F76E8214F62Q37363430-EDFF3320-CD23-4E62-A19C-959349EC64EBQ37374027-94652983-3F2C-4F9D-BEE4-77B3DA4CA53EQ37379254-7D3E5358-3A51-4287-AE18-08F6F0ED7251Q37380159-599A8778-DA6D-4CFB-BD6E-2FED51A483D9Q37407570-61FAA1DD-7F8A-4302-B4B0-E33C2CCC9BDEQ37538631-9AA38055-2B84-4F1C-A343-5AB1B54B6540
P2860
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk models for progression to ...... , genetic, and ocular factors.
@ast
Risk models for progression to ...... , genetic, and ocular factors.
@en
type
label
Risk models for progression to ...... , genetic, and ocular factors.
@ast
Risk models for progression to ...... , genetic, and ocular factors.
@en
prefLabel
Risk models for progression to ...... , genetic, and ocular factors.
@ast
Risk models for progression to ...... , genetic, and ocular factors.
@en
P2093
P2860
P1433
P1476
Risk models for progression to ...... , genetic, and ocular factors.
@en
P2093
Bernard Rosner
Johanna M Seddon
Robyn Reynolds
P2860
P304
P356
10.1016/J.OPHTHA.2011.04.029
P577
2011-09-29T00:00:00Z